Pioglitazone protects against thioacetamide-induced liver fibrosis via AMPK-mediated inhibition of the TGF-β/Smad fibrotic cascade.

Hawary OA, Wadie W, El-Said YAM, Hassan OF

Open source

DOI
10.1007/s00210-026-05903-8
Published
2026 Sep 15
Container
Naunyn-Schmiedeberg's archives of pharmacology
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00210-026-05903-8,
  title = {Pioglitazone protects against thioacetamide-induced liver fibrosis via AMPK-mediated inhibition of the TGF-β/Smad fibrotic cascade.},
  author = {Hawary OA and Wadie W and El-Said YAM and Hassan OF},
  year = {2026},
  journal = {Naunyn-Schmiedeberg's archives of pharmacology},
  doi = {10.1007/s00210-026-05903-8},
  url = {https://doi.org/10.1007/s00210-026-05903-8}
}

RIS

TY  - JOUR
TI  - Pioglitazone protects against thioacetamide-induced liver fibrosis via AMPK-mediated inhibition of the TGF-β/Smad fibrotic cascade.
AU  - Hawary OA
AU  - Wadie W
AU  - El-Said YAM
AU  - Hassan OF
PY  - 2026
JO  - Naunyn-Schmiedeberg's archives of pharmacology
DO  - 10.1007/s00210-026-05903-8
UR  - https://doi.org/10.1007/s00210-026-05903-8
ER  - 

APA

OA, H., W, W., YAM, E., & OF, H. (2026). Pioglitazone protects against thioacetamide-induced liver fibrosis via AMPK-mediated inhibition of the TGF-β/Smad fibrotic cascade.. Naunyn-Schmiedeberg's archives of pharmacology. https://doi.org/10.1007/s00210-026-05903-8

Source records